| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.0M | +61.9% |
| Cost of Revenue | $6.3M | +6.2% |
| Gross Profit | $4.8M | +424.5% |
| R&D Expense | $22.5M | -20.1% |
| SG&A Expense | $20.3M | -37.4% |
| Operating Income | -$48.1M | +34.9% |
| Pre-tax Income | -$44.2M | +39.5% |
| Income Tax | $0 | — |
| Net Income | -$44.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.2M | -36.0% |
| Accounts Receivable | $3.2M | +51.6% |
| Inventory | $6.6M | +42.4% |
| Current Assets | $88.9M | -30.9% |
| Total Assets | $94.2M | -29.7% |
| Current Liabilities | $8.8M | -0.4% |
| Total Liabilities | $9.8M | -5.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.8M | +42.2% |
| Capital Expenditures | $804K | +37.4% |
| Investing Cash Flow | -$804K | -37.4% |
| Financing Cash Flow | $174K | +2385.7% |
| Free Cash Flow | -$42.6M | +41.6% |
| +39.5% |
| EPS (Basic) | -$0.62 | +40.4% |
| EPS (Diluted) | -$0.62 | +40.4% |
| Stockholders' Equity |
| $84.4M |
| -31.8% |